Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Unknown 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Breast Neoplasms 39Neoplasms 37Depression 29Prostatic Neoplasms 23Fatigue 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Multiple Myeloma 15Lymphoma, Follicular 15Lymphoma, Large B-Cell, Diffuse 13Carcinoma, Non-Small-Cell Lung 13Anxiety Disorders 13Lymphoma, Mantle-Cell 12Leukemia, Lymphocytic, Chronic, B-Cell 12Burkitt Lymphoma 12Pain 11Lymphoma, Non-Hodgkin 11Lymphoma, B-Cell, Marginal Zone 11Lung Neoplasms 11Lymphoma, Large-Cell, Immunoblastic 10Leukemia, Myeloid, Acute 10Colorectal Neoplasms 10Leukemia, Myeloid, Chronic-Phase 9Hodgkin Disease 9Blast Crisis 9Vomiting 8Nausea 8Lymphoma 8Leukemia, Myeloid, Accelerated Phase 8Head and Neck Neoplasms 8Uterine Cervical Neoplasms 7

Interventions

Injections 26toripalimab 17pembrolizumab 17tislelizumab 12Gemcitabine 8Cisplatin 7spartalizumab 6atezolizumab 6Irinotecan 6Carboplatin 6Paclitaxel 5Oxaliplatin 5Nivolumab 5Leucovorin 5Fluorouracil 5camrelizumab 4Pemetrexed 4Docetaxel 4Cetuximab 4Capecitabine 4trastuzumab deruxtecan 3sintilimab 3olaparib 3lenvatinib 3cediranib 3PM 01183 3Drug Therapy 3Cyclophosphamide 3Bevacizumab 3Albumin-Bound Paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Advanced Solid Tumor × Therapeutics × Clear all
NCT05673538 2023-01-10

TT-00973-MS Tablets in Patients With Advanced Solid Tumors

TransThera Sciences (Nanjing), Inc.

Phase 1 Unknown
40 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT04423380 2020-06-09

A Study to Investigate Safety and Tolerability of SH3051 Capsule in Patients With Advanced Solid Tumors

Nanjing Sanhome Pharmaceutical, Co., Ltd.

Phase 1 Unknown
45 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡